In the long battle to create an effective HIV vaccine, scientists have made a major leap forward. A new study shows that a ...

In the long battle to create an effective HIV vaccine, scientists have made a major leap forward. A new study shows that a series of ...

Researchers from the Centenary Institute have uncovered a reason why some people with haemophilia A develop resistance to their critical treatment ...

Using deep learning techniques, scientists generated an artificial protein that successfully changes its shape to bind and ...

BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will present clinical trial data from select pipeline candidates across the Company’s diversified oncology portfolio at the American Society of ...

We’re witnessing a renaissance in cytokine targeting,” says Dr. Emily Rhodes, immunologist at the Stanford Institute for ...

How much a stock's price changes over time is a significant driver for most investors. Not only can price performance impact your portfolio, but it can help you compare investment results across ...

Veru's pivot with enobosarm: groundbreaking Phase 2b results enhance GLP-1 therapy outcomes. A positive launch could yield ...

The Hidden Language of GlycansImagine a vast molecular conversation happening within and between cells—where sugar-based structures act as sophisticated messengers carrying critical biological ...

The internationally renowned cancer centre is working on the project – billed as the UK's first large-scale, AI-powered ...